close

Enter

Log in using OpenID

Asia Pacific Insulin Market

embed
The Asia Pacific insulin market is expected to reach USD 15.04 billion by 2020, according to a new study by Grand View Research, Inc.
Asia Pacific Insulin Market Size, Share & Trends Analysis Report and
Segment Forecast, 2020| Grand View Research, Inc
“Growing global prevalence of diabetes and the increasing incidence rates of
lifestyle induced disorders such as obesity are expected to drive insulin market
growth in Asia Pacific region.”
The Asia Pacific Insulin Market is expected to reach USD 15.04 billion by 2020, according to a new study by
Grand View Research, Inc. Growing regional prevalence of diabetes, increasing market penetration rates of
modern insulin products in emerging markets such as India and China is expected to drive market growth during
the forecast period. Furthermore, patent expiration of key products such as Lantus is expected to trigger the
manufacturing of biosimilars from local manufacturers such as Biocon.
Long acting analog dominated the overall market in terms of revenue share in 2013, with revenue estimated at
USD 2,051.9 million. High prices coupled with relatively higher efficacies exhibited by these products account
for its large share. Rapid acting analogs followed the long acting segment in 2013 accounting for a revenue
share of over 25.0% on account of their high market penetration rates in developed markets such as Australia
and Japan.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/asia-pacific-insulin-market
Further key findings from the study suggest:

The analogs source segment accounted for the largest revenue share in 2013 was valued at USD 3,441.7
million. Growing demand for analogs in emerging markets with high unmet medical needs such as China
and India is one of the major factors attributing to its large share.
Follow Us:

Japan, on behalf of its sophisticated healthcare infrastructure, high patient awareness and disposable
income levels dominated the market in 2013 with a revenue share of over 38.0%.

China on the other hand is expected to register the highest CAGR of 21.1% during the forecast period
owing to the growing prevalence of type I and type diabetes and the expected decline in insulin prices
as a result of continued initiatives to improve healthcare access.

The Asia Pacific insulin market is oligopolistic in nature and is dominated by three key players inc luding
Novo Nordisk, Eli Lilly and Sanofi Aventis.
Grand View Research has segmented the Asia Pacific Insulin market on the basis of product, application, source
and region:
Insulin Product Outlook

Rapid acting

Long acting

Premixed

Premixed analog

Short acting

Intermediate acting
Insulin Application Outlook

Type I and Other Diabetes

Type II Diabetes
Insulin Source Outlook

Human Recombinant

Analogs
Insulin Regional Outlook

India

China

Australia

New Zealand
Follow Us:

South Korea

Taiwan

Philippines

Vietnam

Indonesia

Japan

Malaysia

Thailand

Rest of Asia Pacific
Follow Us:
Table of Content of Restorative Dentistry Market
Chapter 1 Executive Summary
Chapter 2 Research Methodology
2.1 Information procurement
2.2 Secondary sources:
2.3 Data Analysis
2.4 Approaches for Region Wise Market Calculation
2.4.1 Region Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 List of Secondary Sources (partial list)
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1 Market Segmentation & Scope
4.2 Market Driver Analysis
4.2.1 Growing number of dental practices with shifting trend towards group practices
4.2.2 Advent of digital dentistry
4.2.3 Increasing demand for cosmetic dentistry and implants
4.2.4 Growth of dental tourism
4.3 Market Restraint Analysis
4.3.1 Lack of adequate reimbursement
4.3.2 Pricing pressure created by key market players
4.4 Penetration & Growth Prospect Mapping
4.5 Restorative dentistry- SWOT analysis, by factor (Political & Legal, Economic and Technological)
4.6 Market SWOT Analysis, By Factor (political & legal, economic and technological)
4.6.1 Political & legal factors
4.6.1.1 Strength
4.6.1.2 Weakness
Follow Us:
4.6.1.3 Opportunity
4.6.1.4 Threat
4.6.2 Economic factors
4.6.2.1 Strength
4.6.2.2 Weakness
4.6.2.3 Opportunity
4.6.2.4 Threat
4.6.3 Technological factors
4.6.3.1 Strength
4.6.3.2 Weakness
4.6.3.3 Opportunity
4.6.3.4 Threat
4.7 Industry Analysis - Porter’s
4.7.1 Porter’s Five Forces Analysis
4.7.1.1 Competitive rivalry
4.7.1.2 Bargaining power of suppliers
4.7.1.3 Bargaining power of buyers
4.7.1.4 Threat of new entrants
4.7.1.5 Threat of substitutes
Chapter 5 Product Estimates & Trend Analysis
5.1 Restorative Dentistry Market: Product movement analysis
5.2 Restorative Materials
5.2.1 Restorative materials market, 2014 - 2025 (USD Million)
5.2.1.1 Direct restorative materials
5.2.1.1.1 Direct restorative materials market, 2014 - 2025 (USD Million)
5.2.1.2 Indirect Restorative Materials
5.2.1.2.1 Indirect restorative materials market, 2014 - 2025 (USD Million)
5.2.1.2.2 All Ceramic
5.2.1.2.3 Metal ceramic
5.2.1.2.4 Metal alloys
5.2.1.2.5 Other indirect restorative materials
Follow Us:
5.2.1.3 Biomaterials
5.2.1.3.1 Biomaterials market, 2014 - 2025 (USD Million)
5.2.1.4 Bonding Agents/Adhesives
5.2.1.5 Bonding agents/adhesives market, 2014 - 2025 (USD Million)
5.2.1.6 Impression materials
5.2.1.6.1 Impression materials market, 2014 - 2025 (USD Million)
5.2.2 Implants
5.2.2.1 Implants market, 2014 - 2025 (USD Million)
5.2.3 Prosthetics
5.2.3.1 Prosthetics market, 2014 - 2025 (USD Million)
5.2.4 Restorative Equipment
5.2.4.1 Restorative equipment market, 2014 - 2025 (USD Million)
5.2.4.2 CAD/CAM systems
5.2.4.2.1 CAD/CAM systems market, 2014 - 2025 (USD Million)
5.2.4.3 Handpieces
5.2.4.3.1 Handpieces market, 2014 - 2025 (USD Million)
5.2.4.4 Rotary instruments
5.2.4.4.1 Rotary instruments market, 2014 - 2025 (USD Million)
5.2.4.5 Light Curing Equipment
5.2.4.5.1 Light curing equipment market, 2014 - 2025 (USD Million)
5.2.4.6 Casting equipment
5.2.4.6.1 Casting equipment market, 2014 - 2025 (USD Million)
5.2.4.7 Mixing equipment
5.2.4.7.1 Mixing equipment market, 2014 - 2025 (USD Million)
5.2.4.8 Articulating equipment
5.2.4.8.1 Articulating equipment market, 2014 - 2025 (USD Million)
5.2.4.9 Other equipment
5.2.4.9.1 Other equipment market, 2014 - 2025 (USD Million)
Chapter 6 End Use Estimates & Trend Analysis
6.1 Restorative dentistry: End use movement analysis
6.2 Dental hospitals & clinics
Follow Us:
6.2.1 Dental hospitals & clinics market, 2014 - 2025 (USD Million)
6.3 Dental labs
6.3.1 Dental labs market, 2014 - 2025 (USD Million)
6.4 Research & teaching institutes
6.4.1 Research & teaching institutes market, 2014 - 2025 (USD Million)
Chapter 7 Regional Estimates & Trend Analysis, by Product & Application
7.1 Restorative Dentistry: Regional Movement Analysis
7.2 North America
7.2.1 North America restorative dentistry market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. restorative dentistry market, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada restorative dentistry market, 2014- 2025 (USD Million)
7.3 Europe
7.3.1 Europe restorative dentistry market, 2014 - 2025 (USD Million)
7.3.2 UK
7.3.2.1 UK restorative dentistry market, 2014 - 2025 (USD Million)
7.3.3 Germany
7.3.3.1 Germany restorative dentistry Market, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific restorative dentistry Market, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan restorative dentistry Market, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China restorative dentistry Market, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America restorative dentistry Market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil restorative dentistry Market, 2014 - 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico restorative dentistry Market, 2014 - 2025 (USD Million)
Follow Us:
7.6 MEA
7.6.1 MEA restorative dentistry Market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa restorative dentistry Market, 2014 - 2025 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia restorative dentistry Market, 2014 - 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 3M Company
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Geographic and Business Segmentation
8.1.1.5 SWOT Analysis
8.1.1.6 Strategic initiatives
8.1.2 Dentsply Sirona
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Geographic and Business Segmentation
8.1.2.5 SWOT Analysis
8.1.2.6 Strategic initiatives
8.1.3 Danaher Corporation
8.1.3.1 Company Overview
8.1.3.2 Financial performance
8.1.3.3 Product Benchmarking
8.1.3.4 Geographic and Business Segmentation
8.1.3.5 SWOT Analysis
8.1.3.6 Strategic initiatives
8.1.4 Mitsui Chemicals, Inc.
8.1.4.1 Company Overview
Follow Us:
8.1.4.2 Financial performance
8.1.4.3 Product Benchmarking
8.1.4.4 Geographic and Business Segmentation
8.1.4.5 SWOT Analysis
8.1.4.6 Strategic initiatives
8.1.5 Institut Straumann AG
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Geographic Segmentation
8.1.5.5 SWOT Analysis
8.1.5.6 Strategic initiatives
8.1.6 Zimmer Biomet Holdings, Inc.
8.1.6.1 Company Overview
8.1.6.2 Financial performance
8.1.6.3 Product Benchmarking
8.1.6.4 Geographic and Business Segmentation
8.1.6.5 SWOT Analysis
8.1.6.6 Strategic initiatives
8.1.7 Septodont Holding
8.1.7.1 Company Overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 SWOT Analysis
8.1.7.5 Strategic initiatives
8.1.8 Ivoclar Vivadent AG
8.1.8.1 Company Overview
8.1.8.1 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 SWOT Analysis
8.1.8.5 Strategic initiatives
Follow Us:
8.1.9 COLTENE Holding AG
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 SWOT Analysis
8.1.9.5 Geographic and Business Segmentation
8.1.9.6 Strategic initiatives
8.1.10 GC Corporation
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 SWOT Analysis
8.1.10.5 Strategic initiatives
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: [email protected]
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:
Follow Us:
Author
sara01.james
sara01.james530   documents Email
Document
Category
Business and Leadership
Views
4
File Size
798 KB
Tags
market, Asia Pacific insulin market, Insulin Market
1/--pages
Report inappropriate content